Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that ten abstracts have been accepted for presentation at ...

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...

Daniella Pierson turned her newsletter side hustle into a $40 million success. She aim to empower women with a new venture ...

CHICAGO, May 15, 2025--(BUSINESS WIRE)--MAIA Biotechnology ... 2 THIO-101 clinical trial was accepted for poster presentation at the 2025 Annual Meeting of the American Society of Clinical ...

today shared the Company's poster presented at the European Society for Medical Oncology's (“ESMO”) Breast Cancer meeting on May 14-17, 2025, in Munich, Germany. A copy of the poster is ...

today announced its abstract has been selected for a poster presentation at the 2025 European Hematology Association Annual Meeting (EHA) being held June 12-15 in Milan, Italy. The abstract ...

has announced the presentation of six posters, including one oral presentation, at the 2025 annual meeting of the Professional Society for Health Economics and Outcomes Research (ISPOR), taking ...

today announced that its Trials in Progress abstract has been selected for poster presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 30 to June 3 ...

will be presenting a poster at the Association for Research in Vision and Ophthalmology (ARVO) 2025 annual meeting highlighting a potentially groundbreaking morphological endpoint. The poster ...

announces that three abstracts have been accepted for poster presentations at the upcoming Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting taking place from May 4 to 8 in ...

These posters highlight key data supporting the rationale for the ... including estimates and projections about future events and trends that we believe may affect our business, financial condition, ...